Medicine by Alexandros G. Sfakianakis,Αλέξανδρος Γ. Σφακιανάκης

A comparison between revised Manchester Point A and ICRU-89–recommended Point A definition absorbed-dose reporting using CT images in intracavitary brachytherapy for patients with cervical carcinoma

Publication date: Available online 16 August 2020Source: BrachytherapyAuthor(s): Ankur Mourya, Sunil Choudhary, Uday Pratap Shahi, Neeraj Sharma, Himani Gautam, Ganeshkumar Patel, Satyajit Pradhan, Lalit Mohan Aggarwal

Education and training for image-guided adaptive brachytherapy for cervix cancer—The (GEC)-ESTRO/EMBRACE perspective

Sun Aug 16, 2020 20:00

Publication date: Available online 16 August 2020Source: BrachytherapyAuthor(s): Li-Tee Tan, Kari Tanderup, Christian Kirisits, Umesh Mahantshetty, Jamema Swamidas, Ina Jürgenliemk-Schulz, Jacob Lindegaard, Astrid de Leeuw, Nicole Nesvacil, Marianne Assenholt, Daniel Berger, Tamara Diendorfer, Johannes Dimopoulos, Simon Duke, Stefan Ecker, Lars Fokdal, Taran Hellebust, Nina Jensen, Kathrin Kirchheiner, Remi Nout

#ThisIsBrachytherapy: Increasing awareness of brachytherapy

Sun Aug 16, 2020 20:00

Publication date: Available online 16 August 2020Source: BrachytherapyAuthor(s): Jenna M. Kahn, Shauna R. Campbell, Ashley A. Albert, Miriam A. Knoll, Chirag Shah

Interstitial high-dose-rate brachytherapy in the treatment of keloids: Moving toward a volumetric approach

Sun Aug 16, 2020 20:00

Publication date: Available online 15 August 2020Source: BrachytherapyAuthor(s): Eric M. Anderson, John David, Tiffany Phillips, John Demarco, Robert S. Reznik, Amin J. Mirhadi, Mitchell Kamrava

Sun Aug 16, 2020 20:00

Mark above section as read

Pharmacokinetics of Efavirenz 600 mg Once Daily During Pregnancy and Post Partum in Ghanaian Women Living with HIV

Publication date: Available online 15 August 2020Source: Clinical TherapeuticsAuthor(s): Margaret Lartey, Ernest Kenu, Anyetei Lassey, Michael Ntumy, Vincent Ganu, Miriam Sam, Isaac Boamah, Fizza S. Gilani, Hongmei Yang, Gena M. Burch, Jennifer Norman, Charles A. Peloquin, Awewura Kwara

Association Between the Overall Risk of Prostate Cancer and Use of Calcium Channel Blockers: A Systematic Review and Meta-Analysis

Sun Aug 16, 2020 16:33

Publication date: Available online 15 August 2020Source: Clinical TherapeuticsAuthor(s): Hui Yang, Yahui Yu, Xiaopeng Hu, Wei Wang, Xiaoyong Yang, Hang Liu, Liang Ren, Xiaodong Zhang, Xin Feng, Lihong Liu

Open-label, Single-dose Studies of the Pharmacokinetics of Edaravone in Subjects with Mild, Moderate, or Severe Hepatic Impairment Compared to Subjects with Normal Hepatic Functioning

Sat Aug 15, 2020 16:38

Publication date: Available online 14 August 2020Source: Clinical TherapeuticsAuthor(s): Yoshinobu Nakamaru, Masae Kakubari, Kaori Yoshida, Makoto Akimoto, Vesna Todorovic, Thomas Greis, Kazuoki Kondo

Sat Aug 15, 2020 00:32

Table of Contents

Publication date: July 2020Source: Clinical Therapeutics, Volume 42, Issue 7Author(s):

Sat Aug 15, 2020 00:32

Editorial Board

Publication date: July 2020Source: Clinical Therapeutics, Volume 42, Issue 7Author(s):

Latest Results for Investigational New Drugs

Sat Aug 15, 2020 00:32

Mark above section as read

Phase I/II study of erlotinib plus S-1 for patients with previously treated non-small cell lung cancer: Thoracic Oncology Research Group (TORG) 0808/0913

Summary Introduction In preclinical data, the combination therapy with S-1 and epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) had a synergistic antitumor effect on non-small cell lung cancer (NSCLC), regardless of the EGFR mutation status. Patients and Methods Patients with previously treated NSCLC and adequate organ function regardless of EGFR mutation status were eligible for the phase I study, with wild-type EGFR were eligible for the phase II study....

Latest Results for Investigational New Drugs

Sat Aug 15, 2020 03:00

Mark above section as read

Influence of FAZA PET hypoxia and HPV-status for the outcome of head and neck squamous cell carcinoma (HNSCC) treated with radiotherapy: Long-term results from the DAHANCA 24 trial (NCT01017224)

Publication date: Available online 14 August 2020Source: Radiotherapy and OncologyAuthor(s): Mette Saksø, Lise Saksø Mortensen, Hanne Primdahl, Jørgen Johansen, Jesper Kallehauge, Christian Rønn Hansen, Jens Overgaard

Towards real time in-vivo rectal dosimetry during trans-rectal ultrasound based high dose rate prostate brachytherapy using MOSkin dosimeters

Sat Aug 15, 2020 18:42

Publication date: Available online 13 August 2020Source: Radiotherapy and OncologyAuthor(s): Joel Poder, Andrew Howie, Ryan Brown, Joseph Bucci, Anatoly Rosenfeld, Komiti Enari, Kristine Scheiber, Mauro Carrara, Andrej Bece, David Malouf, Dean Cutajar

Magnetic resonance imaging guided brachytherapy: Time for non-pelvic cancer? Example of tongue brachytherapy

Fri Aug 14, 2020 18:23

Publication date: Available online 13 August 2020Source: Radiotherapy and OncologyAuthor(s): A. Escande, F. Crop, X. Liem, X. Mirabel, M. Julieron, R. Mouttet-Audouard, S. El Bedoui, E.F. Lartigau, A. Cordoba

Population-based outcomes by immunosuppressed status in patients undergoing radiotherapy for oropharyngeal cancer

Fri Aug 14, 2020 18:23

Publication date: Available online 13 August 2020Source: Radiotherapy and OncologyAuthor(s): Sarah Nicole Hamilton, Ryan Urban, Alvin Liu, Nicole Chau, Eric Berthelet, Eric Tran, Jonn Wu, Yaling Yin, Robert Olson

The declining role of post-treatment neck dissection in human papillomavirus-associated oropharyngeal cancer

Fri Aug 14, 2020 18:23

Publication date: Available online 13 August 2020Source: Radiotherapy and OncologyAuthor(s): Christopher P. Daniels, Howard Yu-hao Liu, Anne Bernard, Christopher Williams, Matthew C. Foote, Rahul Ladwa, Margaret McGrath, Benedict James Panizza, Sandro Virgilio Porceddu